Viewing Study NCT03663166


Ignite Creation Date: 2025-12-24 @ 4:07 PM
Ignite Modification Date: 2026-02-20 @ 1:11 AM
Study NCT ID: NCT03663166
Status: TERMINATED
Last Update Posted: 2023-02-15
First Post: 2018-09-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lung View
None Unresectable NSCLC View
None Radiation View